| Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach HI Munisi, Z Xie, S Sengoku Regenerative Medicine 9 (4), 467-477, 2014 | 6 | 2014 |
| Challenges in commercializing stem cells and regenerative medicine technologies: A case study on dedicated biotech firms in Japan HI Munisi, S Sengoku 2013 Proceedings of PICMET'13: Technology Management in the IT-Driven …, 2013 | 5 | 2013 |
| Examining the Effect of Knowledge Management on Performance of Small Firms in Dare es Salaam: A Case Study of Garage Workshops in Temeke District, Dar es Salaam, Tanzania. P Sotery, HI Munisi East African Journal of Business and Economics 5 (1), 48-61, 2022 | 1 | 2022 |
| The current status and value creation of unlisted biotech drug discovery/development firms (biotech DDFs) in Japan: A holistic approach M Sakurai, HI Munisi, H Kakihara, S Sengoku Proceedings of PICMET'14 Conference: Portland International Center for …, 2014 | 1 | 2014 |
| Entrepreneurial venturing in a consortium: A case of advanced biotech r&d in japan HI Munisi 研究・技術計画学会, 2013 | 1 | 2013 |
| バイオクラスターの形成と経営: 北欧メディコンバレーと仏リヨンにおける取組みの検証, 関西への意味合い HI MUNISI, LETK Yen, E JOLIVET 経済論叢= The economic review/京都大学経済学会 編 186 (4), 1-18, 2013 | | 2013 |
| Structure, Management and Performance of Drug Discovery Firms in Japan HI Munisi, S Sengoku 研究・技術計画学会, 2012 | | 2012 |
Shintaro SengokuTokyo Institute of TechnologyVerified email at m.titech.ac.jp
